These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Cardiovascular effects of prenalterol (H133/22) in normal man. Scott DH; Arthur GR; Boyes RN; Scott DB Br J Clin Pharmacol; 1979 Apr; 7(4):365-70. PubMed ID: 36118 [TBL] [Abstract][Full Text] [Related]
64. Beta-1-adrenoceptor agonists with low adenylate cyclase activation--theoretical and clinical implications. Chemnitius JM; Bing RJ Can J Cardiol; 1985; 1(3):186-90. PubMed ID: 2864992 [TBL] [Abstract][Full Text] [Related]
65. The effects of intravenous prenalterol on ventricular performance, as assessed by radionuclide ventriculography, in patients with ischaemic heart disease. Muir AL; Hannan WJ; Dewhurst NG; Slessor IM Br J Clin Pharmacol; 1981 Oct; 12(4):475-80. PubMed ID: 7295483 [TBL] [Abstract][Full Text] [Related]
66. A dose response study with oral prenalterol in patients with chronic congestive cardiac failure. Hendry WG; Comerford MB; Besterman EM Clin Cardiol; 1984 Jan; 7(1):23-8. PubMed ID: 6705284 [TBL] [Abstract][Full Text] [Related]
67. Prenalterol in cardiogenic shock following acute myocardial infarction. Coma-Canella I; Lopez-Sendon J; Jadraque LM Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265 [TBL] [Abstract][Full Text] [Related]
68. [Prenalterol (CGP 7760 B), a new cardioselective beta 1-adrenoceptor-agonist (author's transl)]. Piepenbrock S; Reichelt W; Zenz M; Seitz W; Sikalieh E Anaesthesist; 1981 Mar; 30(3):118-23. PubMed ID: 6111933 [TBL] [Abstract][Full Text] [Related]
69. Beta adrenergic influence on esophageal and colonic motility in man. Lyrenäs E Scand J Gastroenterol Suppl; 1985; 116():1-48. PubMed ID: 2864739 [TBL] [Abstract][Full Text] [Related]
70. Metabolic effects of prenalterol in diabetic patients. Oltmanns D Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885 [TBL] [Abstract][Full Text] [Related]
72. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy. Erbel R; Meyer J; Lambertz H; Schweizer P; Voelker W; Krebs W; Braun G; Effert S Circulation; 1982 Aug; 66(2):361-9. PubMed ID: 6124326 [No Abstract] [Full Text] [Related]
73. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure. Corea L; Bentivoglio M; Verdecchia P; Provvidenza M G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975 [TBL] [Abstract][Full Text] [Related]
74. Characterization of the beta-adrenoceptor of the adipose cell of the rat. Tan S; Curtis-Prior PB Int J Obes; 1983; 7(5):409-14. PubMed ID: 6139348 [TBL] [Abstract][Full Text] [Related]
75. The effects of neuropeptide Y on myocardial contractility and coronary blood flow. Awad SJ; Einstein R; Potter EK; Richardson DP Br J Pharmacol; 1991 Sep; 104(1):195-201. PubMed ID: 1838493 [TBL] [Abstract][Full Text] [Related]
76. Evidence for an atypical, or beta 3-adrenoceptor in ferret tracheal epithelium. Webber SE; Stock MJ Br J Pharmacol; 1992 Apr; 105(4):857-62. PubMed ID: 1354537 [TBL] [Abstract][Full Text] [Related]
77. Effects of sympathomimetic agonists and antagonists on mucociliary activity. Hybbinette JC; Mercke U Acta Otolaryngol; 1982; 94(1-2):121-30. PubMed ID: 7124379 [TBL] [Abstract][Full Text] [Related]